Alachua Campus Tour Video
With a sustainable network of high-tech, end-to-end manufacturing facilities across North America, Resilience has become a powerhouse in how...
BLOG
Read on
Building Velocity into Fill/Finish Timelines: Your Guide to Quality and Regulatory Success in the CDMO Space
Manufacturing capabilities need innovation proportional to those in therapeutics discovery. Choosing a CDMO partner with the technologies and...
Problem Solving for Aseptic Filling
How the thoughtful adoption of new technology can both problem-solve and future- proof critical processes in biomanufacturing For any forward-facing...
Leveraging Partnerships to Achieve Cell Therapy Success
What impact can partnerships have in cell therapy commercialization success? Eytan Abraham at Resilience discusses the need for a modernized...
Master Cell Banks: Laying the Foundation to Final Product Success
Consider our top 5 FAQs when it comes to MCBs Master cell banks (MCBs) are a critical starting material that lay the foundation for the scale-up and...
Looking Ahead: What Does the Future Have in Store for Nucleic Acid-Based Therapies?
A Q&A with Aaron Larsen Aaron Larsen is the Technical Head for the Nucleic Acids Franchise with Resilience. He began working with nucleic acids back...
Cell Therapy – What Does It Take To Become a Mainstream Option
While cell therapies are still a small segment of therapeutics, the landscape is rapidly changing — with over 1,000 ongoing clinical trials and...
